Pulmonary Hypertension in Hereditary Haemorrhagic Telangiectasia is Associated with Multiple Clinical Conditions

Overview

Journal ERJ Open Res

Specialty Pulmonary Medicine

Date 2021 Feb 3

PMID 33532461

Citations 3

Authors

Victor Margelidon-Cozzolino

Vincent Cottin

Sophie Dupuis-Girod

Julie Traclet

Kais Ahmad

Jean-Francois Mornex

Segolene Turquier

Affiliations

Soon will be listed here.

Abstract

https://bit.ly/34V7HPy.

Citing Articles

Pulmonary vascular manifestations of hereditary haemorrhagic telangiectasia.

Cullivan S, Kevane B, McCullagh B, OConnor T, Condliffe R, Gaine S Pulm Circ. 2024; 14(4):e70007.

PMID: 39588537 PMC: 11586239. DOI: 10.1002/pul2.70007.

Pulmonary hypertension in hereditary hemorrhagic telangiectasia: A clinical review.

Mathavan A, Mathavan A, Reddy R, Jones K, Eagan C, Alnuaimat H Pulm Circ. 2023; 13(4):e12301.

PMID: 37868718 PMC: 10585978. DOI: 10.1002/pul2.12301.

Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAH.

Eichstaedt C, Belge C, Chung W, Graf S, Grunig E, Montani D Eur Respir J. 2022; 61(2).

PMID: 36302552 PMC: 9947314. DOI: 10.1183/13993003.01471-2022.

References

Chaouat A, Coulet F, Favre C, Simonneau G, Weitzenblum E, Soubrier F . Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension. Thorax. 2004; 59(5):446-8. PMC: 1746994. DOI: 10.1136/thx.2003.11890. View

Riera-Mestre A, Mora-Lujan J, Trujillo-Santos J, Del Toro J, Nieto J, Pedrajas J . Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry. Orphanet J Rare Dis. 2019; 14(1):196. PMC: 6688272. DOI: 10.1186/s13023-019-1172-8. View

Ayala E, Kudelko K, Haddad F, Zamanian R, De Jesus Perez V . The intersection of genes and environment: development of pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia and stimulant exposure. Chest. 2012; 141(6):1598-1600. PMC: 3367481. DOI: 10.1378/chest.11-1402. View

Revuz S, Decullier E, Ginon I, Lamblin N, Hatron P, Kaminsky P . Pulmonary hypertension subtypes associated with hereditary haemorrhagic telangiectasia: Haemodynamic profiles and survival probability. PLoS One. 2017; 12(10):e0184227. PMC: 5628806. DOI: 10.1371/journal.pone.0184227. View

Lesca G, Genin E, Blachier C, Olivieri C, Coulet F, Brunet G . Hereditary hemorrhagic telangiectasia: evidence for regional founder effects of ACVRL1 mutations in French and Italian patients. Eur J Hum Genet. 2008; 16(6):742-9. DOI: 10.1038/ejhg.2008.3. View

Rabinovitch M . Pulmonary hypertension: pathophysiology as a basis for clinical decision making. J Heart Lung Transplant. 1999; 18(11):1041-53. DOI: 10.1016/s1053-2498(99)00015-7. View

Dupuis-Girod S, Cottin V, Shovlin C . The Lung in Hereditary Hemorrhagic Telangiectasia. Respiration. 2017; 94(4):315-330. DOI: 10.1159/000479632. View

Traclet J, Khouatra C, Piegay F, Turquier S, Zeghmar S, Mornex J . Pulmonary arterial hypertension in heroin users. J Heart Lung Transplant. 2016; 35(7):932-4. DOI: 10.1016/j.healun.2016.03.019. View

Lyle M, Fenstad E, McGoon M, Frantz R, Krowka M, Kane G . Pulmonary Hypertension in Hereditary Hemorrhagic Telangiectasia. Chest. 2015; 149(2):362-371. DOI: 10.1378/chest.15-0535. View

10.

Harder E, Fares W . Hospitalizations with hereditary hemorrhagic telangiectasia and pulmonary hypertension in the United States from 2000 to 2014. Respir Med. 2019; 147:26-30. DOI: 10.1016/j.rmed.2018.12.013. View

11.

Girerd B, Montani D, Coulet F, Sztrymf B, Yaici A, Jais X . Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation. Am J Respir Crit Care Med. 2010; 181(8):851-61. DOI: 10.1164/rccm.200908-1284OC. View

12.

Trembath R, Thomson J, Machado R, Morgan N, Atkinson C, Winship I . Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med. 2001; 345(5):325-34. DOI: 10.1056/NEJM200108023450503. View

13.

Simonneau G, Montani D, Celermajer D, Denton C, Gatzoulis M, Krowka M . Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2018; 53(1). PMC: 6351336. DOI: 10.1183/13993003.01913-2018. View

14.

Shovlin C, Sulaiman N, Govani F, Jackson J, Begbie M . Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism. Thromb Haemost. 2007; 98(5):1031-9. View